Glimepiride Cf

Glimepiride Cf is a generic oral medication that contains the active ingredient glimepiride, a sulfonylurea antidiabetic agent. It is supplied as tablets for oral use and is marketed in the European Union as a prescription‑only product. The drug is indicated to improve blood‑glucose control in adults with type 2 diabetes mellitus by stimulating insulin release from pancreatic beta cells and may be combined with lifestyle measures.

Glimepiride Cf is prescribed for the management of type 2 diabetes mellitus in adults.

- As monotherapy when diet and exercise are insufficient. - In combination with metformin when additional glucose lowering is needed. - As part of a comprehensive diabetes treatment plan that includes lifestyle modification. - For patients whose glycemic control requires a sulfonylurea agent.

Side effects of Glimepiride Cf vary in frequency and severity.

Common: - Hypoglycemia (low blood sugar). - Weight gain. - Nausea or abdominal discomfort. - Headache. - Dizziness. - Mild rash.

Serious: - Severe hypoglycemia requiring assistance. - Allergic reactions such as angioedema or severe rash. - Blood dyscrasias (e.g., leukopenia, thrombocytopenia). - Hepatic dysfunction or jaundice.

Before starting Glimepiride Cf, certain precautions should be considered.

- Assess renal and hepatic function; dose may need adjustment. - Use caution in elderly patients due to increased hypoglycemia risk. - Avoid in patients with known sulfonylurea hypersensitivity. - Monitor blood glucose regularly to detect hypoglycemia. - Pregnancy and lactation status should be evaluated; safety data are limited. - Review concomitant use of other glucose‑lowering agents.

Glimepiride Cf can interact with several medicines, affecting its efficacy or safety.

Avoid: - Other sulfonylureas or insulin (additive hypoglycemia risk). - Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) which increase glimepiride levels. - MAO‑B inhibitors (e.g., selegiline) may potentiate hypoglycemia.

Use with caution: - Beta‑blockers (may mask hypoglycemia symptoms). - Thiazide diuretics (may reduce glucose‑lowering effect). - NSAIDs (may affect renal function and glucose control). - Certain antidepressants such as SSRIs (potential for altered glycemic control).